178 related articles for article (PubMed ID: 16700883)
1. Monoclonal antibodies as targeting and therapeutic agents: prospects for liver transplantation, hepatitis and hepatocellular carcinoma.
Luk JM; Wong KF
Clin Exp Pharmacol Physiol; 2006; 33(5-6):482-8. PubMed ID: 16700883
[TBL] [Abstract][Full Text] [Related]
2. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
[TBL] [Abstract][Full Text] [Related]
3. Construction and characterization of a high-affinity humanized SM5-1 monoclonal antibody.
Li B; Wang H; Zhang D; Qian W; Hou S; Shi S; Zhao L; Kou G; Cao Z; Dai J; Guo Y
Biochem Biophys Res Commun; 2007 Jun; 357(4):951-6. PubMed ID: 17451647
[TBL] [Abstract][Full Text] [Related]
4. [Status and prospect of antibody-directed targeting treatment for hepatocellular carcinoma].
Yang DH
Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):380-1. PubMed ID: 15918978
[No Abstract] [Full Text] [Related]
5. Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design.
Deyev SM; Lebedenko EN
Bioessays; 2008 Sep; 30(9):904-18. PubMed ID: 18693269
[TBL] [Abstract][Full Text] [Related]
6. Development of humanized antibodies as cancer therapeutics.
Qu Z; Griffiths GL; Wegener WA; Chang CH; Govindan SV; Horak ID; Hansen HJ; Goldenberg DM
Methods; 2005 May; 36(1):84-95. PubMed ID: 15848077
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies in organ transplantation.
Valdés RH
Transplant Proc; 1996 Dec; 28(6):3293. PubMed ID: 8962277
[No Abstract] [Full Text] [Related]
8. [Monoclonal antibodies and therapeutics].
Desgranges C
Pathol Biol (Paris); 2004 Jul; 52(6):351-64. PubMed ID: 15261379
[TBL] [Abstract][Full Text] [Related]
9. Historical development of monoclonal antibody therapeutics.
Nissim A; Chernajovsky Y
Handb Exp Pharmacol; 2008; (181):3-18. PubMed ID: 18071939
[TBL] [Abstract][Full Text] [Related]
10. Antibodies and genetically engineered related molecules: production and purification.
Roque AC; Lowe CR; Taipa MA
Biotechnol Prog; 2004; 20(3):639-54. PubMed ID: 15176864
[TBL] [Abstract][Full Text] [Related]
11. Tumor site-directed therapy for hepatocellular carcinoma using monoclonal antibodies against hepatoma-associated antigens.
Shouval D; Adler R
Prog Liver Dis; 1993; 11():251-67. PubMed ID: 8272514
[No Abstract] [Full Text] [Related]
12. Antibody cocktails: next-generation biopharmaceuticals with improved potency.
Logtenberg T
Trends Biotechnol; 2007 Sep; 25(9):390-4. PubMed ID: 17681390
[TBL] [Abstract][Full Text] [Related]
13. Novel humanized anti-CD3 antibodies induce a predominantly immunoregulatory profile in human peripheral blood mononuclear cells.
Silva HM; Vieira PM; Costa PL; Pimentel BM; Moro AM; Kalil J; Maranhão AQ; Coelho V; Brigido MM
Immunol Lett; 2009 Aug; 125(2):129-36. PubMed ID: 19573559
[TBL] [Abstract][Full Text] [Related]
14. Antibody engineering and modification technologies.
Filpula D
Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589
[TBL] [Abstract][Full Text] [Related]
15. Manufacturing of recombinant therapeutic proteins in microbial systems.
Graumann K; Premstaller A
Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic monoclonal antibodies: a little history, a lot of engineering, and... some clinical successes].
Siberil S; Dutertre CA; Boix C; Teillaud JL
Transfus Clin Biol; 2005 Jun; 12(2):114-22. PubMed ID: 15907389
[TBL] [Abstract][Full Text] [Related]
17. A33scFv-green fluorescent protein, a recombinant single-chain fusion protein for tumor targeting.
Petrausch U; Dernedde J; Coelho V; Panjideh H; Frey D; Fuchs H; Thiel E; Deckert PM
Protein Eng Des Sel; 2007 Dec; 20(12):583-90. PubMed ID: 18033820
[TBL] [Abstract][Full Text] [Related]
18. Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.
Nakamura S; Nouso K; Noguchi Y; Higashi T; Ono T; Jungbluth A; Chen YT; Old LJ; Nakayama E; Shiratori Y
J Gastroenterol Hepatol; 2006 Aug; 21(8):1281-5. PubMed ID: 16872310
[TBL] [Abstract][Full Text] [Related]
19. Humanized antibodies as potential drugs for therapeutic use.
Merluzzi S; Figini M; Colombatti A; Canevari S; Pucillo C
Adv Clin Path; 2000 Apr; 4(2):77-85. PubMed ID: 11080787
[TBL] [Abstract][Full Text] [Related]
20. Engineering therapeutic monoclonal antibodies.
Liu XY; Pop LM; Vitetta ES
Immunol Rev; 2008 Apr; 222():9-27. PubMed ID: 18363992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
